CRSP icon

CRISPR Therapeutics

64 hedge funds and large institutions have $180M invested in CRISPR Therapeutics in 2017 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

16% more capital invested

Capital invested by funds: $155M → $180M (+$24.5M)

0.68% more ownership

Funds ownership: 24.09%24.77% (+0.68%)

97% less call options, than puts

Call options by funds: $27K | Put options by funds: $983K

Holders
64
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$27K
Puts
$983K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$57.6M
2
$35.1M
3
$13.9M
4
$13M
5
$10.2M
6
$9.43M
7
$6.65M
8
$4.71M
9
$3.99M
10
$2.71M
11
$2.66M
12
$2.38M
13
$1.75M
14
$1.53M
15
$1.43M
16
$1.34M
17
$1.21M
18
$1.02M
19
$870K
20
$768K
21
$693K
22
$536K
23
$506K
24
$505K
25
$472K